TOPICS

Tag: Pyoderma Gangrenosum

Consecutive Cases of Pyoderma Gangrenosum Following Dermatologic Surgery

J Clin Aesthet Dermatol. 2020;13(8):49–50 by Brian Wanner, DO; Stephanie Saridakis, DO; and Dawn Sammons, DO Dr. Wanner is a dermatology resident, PGY-3, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Saridakis is an intern, PGY-1, at OhioHealth Riverside Methodist Hospital in Columbus, Ohio. Dr. Sammons is Dermatology Residency Program Director at OhioHealth Riverside

CONTINUE READING »

Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab

 J Clin Aesthet Dermatol. 2019;12(5):28–32 by Raymond E. Kleinfelder, DO; Nady Hin, DO; Stefanie Cubelli, DO; Allan Snyder, PA-C; Francisco Kerdel, BSc, MBBS; and Brad Glick, DO, MPH Drs. Kleinfelder and Hin are with the Dermatology Residency Program at the LECOMT/Larkin Community Hospital, Palm Springs Campus, in Hialeah, Florida. Dr. Cubelli is with St. John’s Episcopal

CONTINUE READING »

A Second Case of Sunitinib-associated Pyoderma Gangrenosum

Steven M. Dean, DO, FACP, RPVI; Matthew Zirwas, MD The Ohio State University, Columbus, Ohio Disclosure: Drs. Dean and Zirwas report no relevant conflicts of interest. Abstract Pyoderma gangrenosum is a painful, noninfectious, ulcerative, cutaneous disorder that most commonly affects the lower extremities. The diagnosis is made by recognizing the characteristic clinical manifestations in the

CONTINUE READING »

Pyoderma Gangrenosum in a Patient with Bruton’s X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha?

by Elissa M. Schwartzfarb, BS, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida; Dot Weir, RN, CWON, CWS, Clinical Director, The Wound Center at Osceola Regional Medical Center, Kissimee, Florida; Walter A. Conlan III, MD, CWS, Medical Director, The Wound Center at Osceola Regional Medical Center, Kissimee, Florida;

CONTINUE READING »